Treosulfan-Based Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Other Myeloid Malignancies

<b>Background:</b> Treosulfan combined with fludarabine (FluTreo) has emerged as a reduced-toxicity alternative to conventional myeloablative conditioning in allogeneic hematopoietic cell transplantation (allo-HCT) for acute myeloid leukemia (AML) and related myeloid malignancies. <b>Purpose:</b> Th...

Descrición completa

Detalles Bibliográficos

Principais autores:	Eleni Gavriilaki, Panagiotis Dolgyras, Ioannis Konstantinidis, Despina Mallouri, Grigorios Salvaras, Christos Demosthenous, Ioannis Batsis, Anna Vardi, Ioannis Papadopoulos, Sophia Tsokkou, Zoi Bousiou, Giorgos Karavalakis, Christos Varelas, Alkistis Panteliadou, Nikolaos Spyridis, Antonia Syrigou, Anastasia Marvaki, Maria Papathanasiou, Apostolia Papalexandri, Chrysavgi Lalayanni, Chrysanthi Vadikoliou, Anastasia Athanasiadou, Ioanna Sakellari
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2025-10-01
Series:	Pharmaceuticals
Assuntos:	allogeneic hematopoietic cell transplantation (allo-HCT) treosulfan reduced-toxicity conditioning acute myeloid leukemia (AML) myelodysplastic syndrome (MDS) myelofibrosis (MF)
Acceso en liña:	https://www.mdpi.com/1424-8247/18/11/1631
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!